Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
About
Media
Watch time: 3m 25s
Watch time: 7m 44s
Watch time: 9m 40s
Articles
Reducing the Threat of Vascular Disease in Patients with Hypertension and Hyperlipidemia by Addressing Poor Adherence
Citation:
US Cardiology 2006;3(2):22–3
- Views:
69
- Downloads:
0
Overview to Antihypertensive and Lipid-lowering Therapies and Patient Care
Citation:
US Cardiology 2006;3(2):18–9
- Views:
65
- Downloads:
0
Adherence to Lipid Lowering—Growing Clinical Challenge
Citation:
US Cardiology 2006;3(2):24–7
- Views:
131
- Downloads:
0